These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 38880226

  • 1. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
    Wu S, Wang H, Yang Q, Liu Z, Du J, Wang L, Chen S, Lu Q, Yang DH.
    Cancer Lett; 2024 Aug 10; 597():217058. PubMed ID: 38880226
    [Abstract] [Full Text] [Related]

  • 2. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H, Shen L, Yang H, Gong H, Du X, Li J.
    IUBMB Life; 2021 Jan 10; 73(1):108-117. PubMed ID: 33205540
    [Abstract] [Full Text] [Related]

  • 3. METTL3-mediated m6A modification promotes processing and maturation of pri-miRNA-19a to facilitate nasopharyngeal carcinoma cell proliferation and invasion.
    Gong Y, Jiang Q, Liu L, Liao Q, Yu J, Xiang Z, Luo X.
    Physiol Genomics; 2022 Sep 01; 54(9):337-349. PubMed ID: 35759451
    [Abstract] [Full Text] [Related]

  • 4. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S, Lu X, Zheng D, Chen W, Li Y, Li F.
    J Cancer Res Clin Oncol; 2022 Dec 01; 148(12):3485-3499. PubMed ID: 35907010
    [Abstract] [Full Text] [Related]

  • 5. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G, Liu J, Wang Y, Liu H, Fu J, Zhao Y, Huang Y.
    Environ Toxicol; 2023 Oct 01; 38(10):2377-2390. PubMed ID: 37449729
    [Abstract] [Full Text] [Related]

  • 6. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, Wei JF, Yang H.
    Mol Cancer; 2019 Jun 22; 18(1):110. PubMed ID: 31228940
    [Abstract] [Full Text] [Related]

  • 7. m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
    Jin D, Guo J, Wu Y, Du J, Yang L, Wang X, Di W, Hu B, An J, Kong L, Pan L, Su G.
    J Hematol Oncol; 2019 Dec 09; 12(1):135. PubMed ID: 31818312
    [Abstract] [Full Text] [Related]

  • 8. METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
    Lin S, Zhu Y, Ji C, Yu W, Zhang C, Tan L, Long M, Luo D, Peng X.
    J Clin Endocrinol Metab; 2022 Jan 18; 107(2):474-490. PubMed ID: 34562008
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X, Zhang Z, Wang L, Zhang S, Ren L, Li S, Xu J, Lv S.
    Bioengineered; 2021 Dec 18; 12(2):10023-10036. PubMed ID: 34666602
    [Abstract] [Full Text] [Related]

  • 10. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
    Qian K, Xu W, Xia X, Ding J.
    Genes Genomics; 2022 Dec 18; 44(12):1519-1530. PubMed ID: 36040683
    [Abstract] [Full Text] [Related]

  • 11. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y, Peng C, Chen J, Chen D, Yang B, He B, Hu W, Zhang Y, Liu H, Dai L, Xie H, Zhou L, Wu J, Zheng S.
    Mol Cancer; 2019 Aug 22; 18(1):127. PubMed ID: 31438961
    [Abstract] [Full Text] [Related]

  • 12. METTL3/IGF2BP1 influences the development of non-small-cell lung cancer by mediating m6A methylation modification of TRPV1.
    Bai W, Xiao G, Xie G, Chen Z, Xu X, Zeng J, Xie J.
    Thorac Cancer; 2024 Sep 22; 15(26):1871-1881. PubMed ID: 39090761
    [Abstract] [Full Text] [Related]

  • 13. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.
    Bao J, Xu T, Wang W, Xu H, Chen X, Xia R.
    Mol Cell Biochem; 2024 Nov 22; 479(11):3077-3089. PubMed ID: 38180718
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X, Wang Z, Li J, Zhu J, Ren Z, Zhang D, Zhao W, Fan Y, Zhang D, Sun R.
    Cell Prolif; 2020 Mar 22; 53(3):e12768. PubMed ID: 31967701
    [Abstract] [Full Text] [Related]

  • 16. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1.
    Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, Li X, Lv X, Zou C.
    J Immunol Res; 2021 Mar 22; 2021():6149558. PubMed ID: 34476262
    [Abstract] [Full Text] [Related]

  • 17. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM, Qi FF, Wang J, Duan YY, Zhao LL, Wang YD, Zhang TC, Liao XH.
    Int J Mol Sci; 2022 Jun 09; 23(12):. PubMed ID: 35742899
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of METTL3-mediated m6A modification in depression-induced cognitive deficits.
    Niu J, Wang B, Wang T, Zhou T.
    Am J Med Genet B Neuropsychiatr Genet; 2022 Apr 09; 189(3-4):86-99. PubMed ID: 35591810
    [Abstract] [Full Text] [Related]

  • 19. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
    Chang M, Wang Z, Gao J, Yang C, Feng M, Niu Y, Tong WM, Bao X, Wang R.
    J Clin Endocrinol Metab; 2022 Jan 01; 107(1):136-149. PubMed ID: 34491359
    [Abstract] [Full Text] [Related]

  • 20. miR-302a-3p suppresses melanoma cell progression via targeting METTL3.
    Chang X, Lin YY, Bai LN, Zhu W.
    J Chemother; 2022 Feb 01; 34(1):55-66. PubMed ID: 34286671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.